The 2015 Gastrointestinal Cancers Symposium (San Francisco, CA, USA; January 15–17) is the world-class conference co-sponsored by the American Society of Clinical Oncology, the American Society for Radiation Oncology, the American Gastroenterological Association Institute, and the Society of Surgical Oncology, in which the most innovative research results in digestive tract oncology are presented and discussed. In its twelfth edition, the meeting has provided new insights focusing on the underpinning biology and clinical management of gastrointestinal malignancies. More than 3,400 health care professionals gathered from all over the world to share their experiences on how to bridge the recent novelties in cancer biology with everyday medica...
Last year the field of immunotherapy was finally introduced to GI oncology, with several changes in ...
Colorectal carcinoma accounts for the majority of all gastrointestinal cancers and is the second lea...
Progress has been made in the treatment of gastrointestinal cancers through advances in systemic the...
The 2015 Gastrointestinal Cancers Symposium (San Francisco, CA, USA; January 15–17) is the world-cla...
The 2015 Gastrointestinal Cancers Symposium (San Francisco, CA, USA; January 15-17) is the world-cla...
Biliary tract cancer; Colorectal cancer; Drug developmentCáncer del tracto biliar; Cáncer colorrecta...
8noGastrointestinal (GI) tumors are among the leading cause of death in cancer patients worldwide. P...
Gastrointestinal cancers, such as esophageal and gastric cancers, pancreatic cancers, hepatobiliary ...
Cancers of the digestive system remain highly lethal; therefore, the care of patients with malignant...
In the GI tumors area, key findings from the American Society of Clinical Oncology 2013 annual meeti...
Despite significant progress in our understanding of the etiology, biology and genetics of colorecta...
Gastrointestinal cancers are a group of highly aggressive malignancies, and novel therapeutic strate...
Introduction: In the GI tumors area, key findings from the American Society of Clinical Oncology 201...
Gastrointestinal cancers are a group of highly aggressive malignancies, and novel therapeutic strate...
Gastrointestinal (GI) cancers are among the most deadly malignancies. Although serial incremental su...
Last year the field of immunotherapy was finally introduced to GI oncology, with several changes in ...
Colorectal carcinoma accounts for the majority of all gastrointestinal cancers and is the second lea...
Progress has been made in the treatment of gastrointestinal cancers through advances in systemic the...
The 2015 Gastrointestinal Cancers Symposium (San Francisco, CA, USA; January 15–17) is the world-cla...
The 2015 Gastrointestinal Cancers Symposium (San Francisco, CA, USA; January 15-17) is the world-cla...
Biliary tract cancer; Colorectal cancer; Drug developmentCáncer del tracto biliar; Cáncer colorrecta...
8noGastrointestinal (GI) tumors are among the leading cause of death in cancer patients worldwide. P...
Gastrointestinal cancers, such as esophageal and gastric cancers, pancreatic cancers, hepatobiliary ...
Cancers of the digestive system remain highly lethal; therefore, the care of patients with malignant...
In the GI tumors area, key findings from the American Society of Clinical Oncology 2013 annual meeti...
Despite significant progress in our understanding of the etiology, biology and genetics of colorecta...
Gastrointestinal cancers are a group of highly aggressive malignancies, and novel therapeutic strate...
Introduction: In the GI tumors area, key findings from the American Society of Clinical Oncology 201...
Gastrointestinal cancers are a group of highly aggressive malignancies, and novel therapeutic strate...
Gastrointestinal (GI) cancers are among the most deadly malignancies. Although serial incremental su...
Last year the field of immunotherapy was finally introduced to GI oncology, with several changes in ...
Colorectal carcinoma accounts for the majority of all gastrointestinal cancers and is the second lea...
Progress has been made in the treatment of gastrointestinal cancers through advances in systemic the...